期刊文献+

心血管病住院患者并发肺部感染的原因及对策 被引量:1

Reason of Hospitalized Patients With Cardiovascular Disease Complicated With Lung Infection and Countermeasures
下载PDF
导出
摘要 目的对心血管病住院患者并发肺部感染的原因进行分析,并探讨积极的应对对策。方法将我院124例心血管病并发肺部感染患者作为研究组,并将同期我院100例心血管病住院患者未合并肺部感染的患者作为对照组。结果两组在年龄≥65岁、慢性阻塞性肺疾病(COPD)病史、卧床以及心力衰竭等因素方面对比(P<0.05);多因素Logisitic回归性分析,结果显示,年龄≥65岁、COPD病史、心力衰竭以及卧床等多因素属于心力衰竭患者发生肺部感染症状的重要独立性危险因素。结论年龄超过65岁、心力衰竭、COPD以及卧床等因素会使心力衰竭患者并发肺部感染,且以上均为独立危险因素,需要对其采取积极的预防措施,有效预防肺部感染。 Objective To analyze the causes of pulmonary infection in patients with cardiovascular disease,and to explore the positive coping strategies. Methods 124 cases of patients with cardiovascular disease complicated with pulmonary infection as the research group,and the same period in our hospital 100 cases of patients with cardiovascular disease without pulmonary infection as the control group. Results The two groups in age over 65 years of age,chronic obstructive pulmonary disease(COPD)history,bed and heart failure factors comparative(P〈0.05),multi factor Logistic regression analysis,the results show,age over 65 years of age,history of COPD,heart failure,and the bed belongs to in patients with heart failure symptoms of pulmonary infection of the important independent risk factors. Conclusion The age of 65 years old,heart failure,COPD and bed and other factors can cause heart failure patients complicated with pulmonary infection,and more are independent risk factors,need to take active preventive measures to prevent pulmonary infection.
作者 魏星
出处 《中国卫生标准管理》 2015年第22期184-185,共2页 China Health Standard Management
关键词 心血管病 住院患者 并发肺部感染 原因 对策 Cardiovascular disease Hospitalized patients Complicated with lung infection Reason Countermeasures
  • 相关文献

参考文献4

二级参考文献33

  • 1Drakopoulou M,Toutouzas K,Stefanadi E,et al.Associationof inflammatory markers with angiographic severity and extentof coronary artery disease[J].Atherosclerosis,2009,206(2):335-339.
  • 2Dallas J,Kollef M.Severe hospital-acquired pneumonia:a re-view for clinicians[J].Curr Infect Dis Rep,2009,11(5):349-356.
  • 3Hong YJ,Jeong MH,Choi YH,et al.Plaque characteristics inculprit lesions and inflammatory status in diabetic acute coro-nary syndrome patients[J].JACC Cardiovasc Imaging,2009,2(3):339-349.
  • 4Warren O, Mandal K, Hadjianastassiou V, et al. Recombinant activated factor Ⅶ in cardiacsurgery : a systematic review [ J]. Ann Thorac Surg, 2007,83 (2) :707-714.
  • 5Crabtree TD, Codd JE, Fraser VJ, et al. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypassgrafting at a tertiary care medical center [J]. Semin Thorac Cardiovasc Surg, 2004, 16(1):53-61.
  • 6Karkouti K, Wijeysundera DN, Yau TM, et al. The independent association of massive blood loss with mortality in cardiac surgery [J]. Transfusion, 2004, 44(10) : 1453-1462.
  • 7Warren O, Mandal K, Hadjianastassiou V, et al.Recombinant activated factor VII in cardiac surgery: a systematic review [ J ]. Ann Thorac Surg, 2007,83(2):707-714.
  • 8Raivio P, Suojaranta-Ylinen R, Kuitunen AH. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery [J]. Ann Thorac Surg 2005,80( 1 ) : 66-71.
  • 9McQuihen ZK, Barnes C, Zatta A, Phillips LE, et al. Off-label use of recombinant factor VIIa in pediatric patients [J]. Pediatrics,2012,129(6) : e1533-1540.
  • 10Suzanne Watnick,Susan T. Crowley.ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past[J]. American Journal of Kidney Diseases . 2013

共引文献31

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部